SDZ ASM 981: Phase III

In NOVN's two 6-week Phase III studies in 403 pediatric patients with mild

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE